Intervention not reported
Quality of life (at study completion) EuroQol (VAS) from 0 to 200 mm; higher score means better function · People with hip or knee osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse effects (related to the exercise programs) · People with hip or knee osteoarthritis
It is very uncertain whether the intervention changes adverse effects (related to the exercise programs) (very low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events or withdrawals (due to adverse events) ‐ not reported · People with hip or knee osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain ‐ duration exercise WOMAC (VAS or Likert) from 0 to 20 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Pain ‐ resistance exercise WOMAC (VAS or Likert) from 0 to 20 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Function ‐ duration exercise WOMAC from 0 to 68 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Function ‐ resistance exercise WOMAC from 0 to 68 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Intervention not reported
Total mortality Systolic targets · Diabetes Mellitus with elevated blood pressure
The intervention showed no clear difference in total mortality Systolic targets (low certainty).
1 finding from 1 review
Intervention not reported
Total mortality Diastolic targets · Diabetes Mellitus with elevated blood pressure
It is very uncertain whether the intervention changes total mortality Diastolic targets (very low certainty).
1 finding from 1 review
Intervention not reported
Total serious adverse events Systolic targets · Diabetes Mellitus with elevated blood pressure
The intervention showed no clear difference in total serious adverse events Systolic targets (low certainty).
1 finding from 1 review
Intervention not reported
Creatine phosphate 1g/day · patients with heart failure
1 finding from 1 review
Intervention not reported
Creatine 20g/day for 6 weeks · patients with heart failure
1 finding from 1 review
Intervention not reported
Creatine 20g/day for 10 days · patients with heart failure
1 finding from 1 review
Intervention not reported
Creatinine phosphate 1g/day for 6 months · patients with heart failure
1 finding from 1 review
Intervention not reported
Creatinine phosphate 1g/day for 3 months · patients with heart failure
1 finding from 1 review
Intervention not reported
Peak exercise capacity: Power (W) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise capacity: Peak oxygen consumption (VO2peak) (L/min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Lactate threshold (L/min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Isowork minute ventilation (VE) (L) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Isowork dyspnoea score · people with chronic obstructive pulmonary disease
1 finding from 1 review